Clarifying Optimal Sodium Intake Project

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

Also called NCT02738736

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 269 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02738736
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Ireland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02738736. Randomized; no masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2020-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clarifying Optimal Sodium Intake Project
Acronym
COSIP-1
Condition
Blood Pressure
Condition
Hypertension
Condition
Kidney Disease
Condition
Cardiovascular Disease
Intervention (Behavioral)
Sodium Reduction
Lead sponsor
University College Hospital Galway (class: other)
Collaborator
European Research Council (class: other)
Collaborator
National University of Ireland, Galway, Ireland (class: other)

Record details

Record id
cardio:ct-nct02738736
Content hash
e56b8eb80f4519bad45036b1dc981d5adfe61fb31b62748983905de974adc255